OA10968A - Comprimé de maléate de trimébutine pelliculé - Google Patents

Comprimé de maléate de trimébutine pelliculé Download PDF

Info

Publication number
OA10968A
OA10968A OA9900020A OA9900020A OA10968A OA 10968 A OA10968 A OA 10968A OA 9900020 A OA9900020 A OA 9900020A OA 9900020 A OA9900020 A OA 9900020A OA 10968 A OA10968 A OA 10968A
Authority
OA
OAPI
Prior art keywords
film
trimebutine
mpa
maleate
tablets
Prior art date
Application number
OA9900020A
Other languages
English (en)
French (fr)
Inventor
Loutfy Benkerrour
Bernard Doat
Original Assignee
Parke Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA10968(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Parke Davis filed Critical Parke Davis
Publication of OA10968A publication Critical patent/OA10968A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
OA9900020A 1996-08-07 1999-01-29 Comprimé de maléate de trimébutine pelliculé OA10968A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609956A FR2752162B1 (fr) 1996-08-07 1996-08-07 Comprime de maleate de trimebutine pellicule

Publications (1)

Publication Number Publication Date
OA10968A true OA10968A (fr) 2001-10-30

Family

ID=9494890

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900020A OA10968A (fr) 1996-08-07 1999-01-29 Comprimé de maléate de trimébutine pelliculé

Country Status (27)

Country Link
EP (1) EP0942718B1 (ru)
JP (1) JP2000515535A (ru)
KR (1) KR100539642B1 (ru)
CN (1) CN1206986C (ru)
AR (1) AR008820A1 (ru)
AT (1) ATE300297T1 (ru)
AU (1) AU3697097A (ru)
BR (1) BR9711032B1 (ru)
CA (1) CA2256751C (ru)
CO (1) CO4900042A1 (ru)
CZ (1) CZ294195B6 (ru)
DZ (1) DZ2272A1 (ru)
EA (1) EA001506B1 (ru)
ES (2) ES2244002T3 (ru)
FR (1) FR2752162B1 (ru)
GR (1) GR1002907B (ru)
HK (1) HK1020888A1 (ru)
HU (1) HU228040B1 (ru)
IT (1) IT1294671B1 (ru)
MX (2) MXPA98010007A (ru)
OA (1) OA10968A (ru)
PL (1) PL188839B1 (ru)
PT (2) PT942718E (ru)
TN (1) TNSN97134A1 (ru)
TR (1) TR199900261T2 (ru)
UA (1) UA52682C2 (ru)
WO (1) WO1998005320A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
FR2834889B1 (fr) 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
EP1726621A1 (en) * 2005-05-26 2006-11-29 Cytec Surface Specialties, S.A. Thermosetting powder compositions
CN100393311C (zh) * 2006-01-26 2008-06-11 孙伟丰 马来酸曲美布汀分散片
CN1927185B (zh) * 2006-10-19 2010-05-19 开开援生制药股份有限公司 具速释部分的马来酸曲美布汀缓释片及其制备工艺
BRPI0916689A2 (pt) 2008-07-28 2015-11-17 Takeda Pharmaceutical composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
KR101048487B1 (ko) * 2008-08-19 2011-07-11 한국콜마 주식회사 말레인산트리메부틴 서방정
KR101220829B1 (ko) * 2010-07-16 2013-01-10 안국약품 주식회사 트리메부틴 함유 서방성 정제
CN102462657A (zh) * 2010-11-15 2012-05-23 杭州赛利药物研究所有限公司 马来酸曲美布汀栓剂及其制备方法
WO2014148520A1 (ja) * 2013-03-21 2014-09-25 大正製薬株式会社 固形製剤
RU2536254C1 (ru) * 2013-11-26 2014-12-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки-ретард с тримебутином
CN107205984B (zh) * 2015-01-26 2019-11-12 第一三共株式会社 吡咯甲酰胺的固体组合物
RU2706166C2 (ru) * 2017-11-20 2019-11-14 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770300C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770301C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
CN113171353B (zh) * 2021-04-25 2022-10-21 海南普利制药股份有限公司 一种马来酸曲美布汀片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
FR2640876B1 (ru) * 1988-12-28 1993-09-24 Jouveinal Sa
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JP2836493B2 (ja) * 1994-08-04 1998-12-14 田辺製薬株式会社 苦味隠蔽されたマレイン酸トリメブチン含有製剤

Also Published As

Publication number Publication date
EP0942718A1 (fr) 1999-09-22
PL188839B1 (pl) 2005-05-31
MX9706053A (es) 1998-02-28
ES2244002T3 (es) 2005-12-01
EA199900102A1 (ru) 1999-06-24
PT102031A (pt) 1998-02-27
MXPA98010007A (es) 2002-07-22
AR008820A1 (es) 2000-02-23
CZ37699A3 (cs) 1999-05-12
TNSN97134A1 (fr) 2005-03-15
CN1226162A (zh) 1999-08-18
IT1294671B1 (it) 1999-04-12
ES2130081B1 (es) 2000-01-01
CA2256751A1 (fr) 1998-02-12
HU228040B1 (en) 2012-09-28
BR9711032B1 (pt) 2008-11-18
ATE300297T1 (de) 2005-08-15
PT102031B (pt) 2004-07-30
KR100539642B1 (ko) 2005-12-29
EA001506B1 (ru) 2001-04-23
PL331517A1 (en) 1999-07-19
BR9711032A (pt) 1999-08-17
CO4900042A1 (es) 2000-03-27
FR2752162B1 (fr) 1998-11-06
CZ294195B6 (cs) 2004-10-13
UA52682C2 (ru) 2003-01-15
CN1206986C (zh) 2005-06-22
HUP9902878A2 (hu) 2000-04-28
HUP9902878A3 (en) 2000-11-28
PT942718E (pt) 2005-10-31
JP2000515535A (ja) 2000-11-21
HK1020888A1 (en) 2000-05-26
WO1998005320A1 (fr) 1998-02-12
AU3697097A (en) 1998-02-25
CA2256751C (en) 2008-09-23
EP0942718B1 (fr) 2005-07-27
FR2752162A1 (fr) 1998-02-13
DZ2272A1 (fr) 2004-06-20
ES2130081A1 (es) 1999-06-16
ITGE970067A1 (it) 1999-02-06
KR20000029866A (ko) 2000-05-25
TR199900261T2 (xx) 1999-04-21
GR1002907B (el) 1998-05-13

Similar Documents

Publication Publication Date Title
EP0942718B1 (fr) Comprime de maleate de trimebutine pellicule
CA2219475C (fr) Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
EP2605757B1 (fr) Formulations a base de nalbuphine et leurs utilisations
JPH0251402B2 (ru)
KR100660072B1 (ko) 음식물 효과-비의존적으로 방출되는 다중 단위 제약 제제및 그의 제조 방법
HU231114B1 (hu) Mikofenolsavat vagy mikofenolátot tartalmazó gyógyszerkészítmények
WO2008113901A2 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
JP2002531395A (ja) 医薬合剤
CA2123232C (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
EP1126829B1 (fr) Particules enrobees d'ibuprofene cristallin granule
MXPA97006053A (en) Compressed trimebutin maleate with lami coating
EP1646379B1 (fr) Nouvelle composition pharmaceutique solide comprenant de l amisulpride
US20090017122A1 (en) Drug Forms Having Controlled Bioavailability
US20100086590A1 (en) Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
US20080274997A1 (en) Stable Granulates Containing S-adenosylmethionine and Process for Preparation Thereof
US11260055B2 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
WO2012107090A1 (en) Granulated composition comprising tadalafil and a disintegrant
FR2995212A1 (fr) Composition pharmaceutique comprenant de la lacidipine et procede de preparation
US20100172986A1 (en) Controlled release composition and preparation thereof
JP5321454B2 (ja) 医薬錠剤の製造法
Ananth Formulation Development and Evaluation of Mycophenolate Sodium 360mg Delayedrelease Tablets
JP2009542806A (ja) 感湿性薬物及び第２薬物の組合せを含んで成る安定製剤及びその製造方法